Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B-Cell Lymphoma (DLBCL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Bethune Hospital of Jilin University, Changchun, Jilin, China
Contact: Study coordinator (Ou Bai, PHD) · oubai16@163.com · 13039046656

Study leads

Ou Bai, PHD
Principal Investigator
The First Bethune Hospital of Jilin University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma

DLBCL

Abroad (travel likely)RecruitingPHASE2

Rochester, United States

R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tianjin, China

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Diffuse Large B-Cell Lymphoma

IsraelRecruitingPHASE3

Mobile, United States · Gilbert, United States

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma (DLBCL)

IsraelRecruitingPHASE3

Los Angeles, United States · Orange, United States